Health Catalyst, Inc.
HCAT
$2.99
$0.072.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 316.06M | 316.09M | 311.27M | 306.58M | 302.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 316.06M | 316.09M | 311.27M | 306.58M | 302.06M |
| Cost of Revenue | 165.96M | 170.69M | 168.28M | 164.79M | 162.59M |
| Gross Profit | 150.11M | 145.41M | 143.00M | 141.79M | 139.47M |
| SG&A Expenses | 98.80M | 98.18M | 96.54M | 100.65M | 103.32M |
| Depreciation & Amortization | 47.88M | 45.25M | 43.23M | 41.43M | 41.47M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 363.77M | 368.35M | 363.97M | 363.68M | 366.31M |
| Operating Income | -47.71M | -52.26M | -52.69M | -57.10M | -64.25M |
| Income Before Tax | -106.66M | -99.67M | -72.22M | -69.17M | -79.29M |
| Income Tax Expenses | 962.00K | 446.00K | 435.00K | 333.00K | -149.00K |
| Earnings from Continuing Operations | -107.62 | -100.12 | -72.66 | -69.50 | -79.14 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -107.62M | -100.12M | -72.66M | -69.50M | -79.14M |
| EBIT | -47.71M | -52.26M | -52.69M | -57.10M | -64.25M |
| EBITDA | -11.43M | -17.90M | -19.67M | -25.37M | -32.08M |
| EPS Basic | -1.58 | -1.51 | -1.15 | -1.15 | -1.35 |
| Normalized Basic EPS | -0.58 | -0.61 | -0.57 | -0.59 | -0.62 |
| EPS Diluted | -1.58 | -1.51 | -1.15 | -1.15 | -1.35 |
| Normalized Diluted EPS | -0.58 | -0.61 | -0.57 | -0.59 | -0.62 |
| Average Basic Shares Outstanding | 270.93M | 261.00M | 250.67M | 240.71M | 235.81M |
| Average Diluted Shares Outstanding | 270.93M | 261.00M | 250.67M | 240.71M | 235.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |